Thomas Leggett, Chief Financial Officer at Black Diamond Therapeutics, Inc. (BDTX), sold 4,941 shares at $34.05 ($167K) on 2020-12-08, disclosed to the SEC on 2020-12-10.
Open-market sale of $167k BDTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.27 | 1,059 | $35K | 21.0% |
| 2 | $34.05 | 1,941 | $66K | 39.5% |
| 3 | $34.05 | 1,941 | $66K | 39.5% |
| Total | $33.88 avg | 4,941 | $167K | 100% |
| Filing → |
| BDTX | SELL | 2020-11-12 | $99K | — | Filing → |
| BDTX | SELL | 2020-10-09 | $101K | — | Filing → |
| BDTX | SELL | 2020-09-16 | $93K | — | Filing → |